People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Volastra Therapeutics, Inc. | — | Biotechnology | Series C | $105.3M | $170.7M | 2023 |
| Prosensa Holding N.V. | — | Biotechnology | Series C | $50.5M | $2.1B | 2014 |
| Erytech Pharma | — | Biotechnology | Series B | $41.2M | $157.0M | 2015 |
| Summation Bio, Inc. | — | Biotechnology | Series B | $24.5M | $464.5M | 2022 |
Luc Dochez at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Luc Dochez on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amy Schulman | 1 | 11 |
| David Mott | 1 | 9 |
| Annalisa Jenkins | 1 | 8 |
| Michael Wyzga | 1 | 5 |
| Robert Mittendorff | 1 | 5 |
| David Nicholson | 1 | 5 |
| David Southwell | 1 | 3 |
| Reza Halse | 1 | 3 |
| Stefan Vitorovic | 1 | 3 |
| Sandra Peterson | 1 | 2 |
| Peter Goodfellow | 1 | 2 |
| Giles Campion | 1 | 2 |
| Martijn Kleijwegt | 1 | 2 |
| Ellie McGuire | 1 | 2 |
| Gerald Sewack | 1 | 2 |
| Berndt Modig | 1 | 2 |
| Arjun Balar | 1 | 1 |
| Gil BEYEN | 1 | 1 |
| Jill Goldstein | 1 | 1 |
| Philippe ARCHINARD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.